If an emmetropic ‘high risk’ patient has presented with a positive family history of myopia these outcomes will be assessed at 6–12 month visits even if they are not undergoing myopia control.
Based on the findings at the first visit a discussion will be had with the patient/parents on the most appropriate choice of myopia control. At present the options available include MiSight daily lenses and orthokeratology. Depending on which option is chosen the patient will be fitted with the contact lenses at a second visit. Any patient undergoing myopia control will be monitored every 6–12 months to determine the efficacy of the treatment.